Form 4: American Tower Corp Director Samme L. Thompson Executes Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Director Samme L. Thompson exercised options and sold shares of American Tower Corp (AMT) on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 1, 2024, Samme L. Thompson, a director of American Tower Corp (AMT), executed an option to purchase 2,527 shares of common stock at a price of $81.18.
  • Simultaneously, Thompson sold 2,527 shares of common stock at $198.9 per share.
  • These transactions were conducted under a Rule 10b5-1 trading plan adopted on October 27, 2023.
  • Following these transactions, Thompson directly owns 23,171 shares of American Tower Corp.
  • The option exercised was granted under the 2007 Equity Incentive Plan, as amended, and was originally granted on March 10, 2014, with an expiration date of March 10, 2024.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. The transactions were pre-planned under a 10b5-1 plan, so they don't necessarily indicate a positive or negative outlook on the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company directors and officers, allowing investors to monitor potential alignment of interests between management and shareholders. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on any material non-public information.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders.
  • The use of a 10b5-1 trading plan is a common method for corporate insiders to sell shares without raising concerns about insider trading.
  • Comparable companies such as Crown Castle International (CCI) and SBA Communications (SBAC) also have similar insider transaction disclosures.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • The disclosure provides transparency to shareholders regarding insider trading activity.

Key Dates

DateDescription
03/10/2014Original grant date of the option to purchase common stock.
10/27/2023Date the reporting person adopted the Rule 10b5-1 trading plan.
03/01/2024Date of the transaction: option exercise and stock sale.
03/05/2024Date of the Form 4 filing.
03/10/2024Expiration date of the option to purchase common stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.